Biotech · Private company
ImmunoGenesis
Track this companyFree. Adds ImmunoGenesis to your Dealase workspace and tells you when its record changes.
Clinical trials82 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- GemcitabinePhase 3 · Metastatic or Locally Advanced Unresectable Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TH-302Phase 3 · Metastatic or Locally Advanced Unresectable Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- BalstilimabPhase 2 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- EvofosfamidePhase 2 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- Gemzar (Gemcitabine)Phase 2 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TH-302Phase 2 · Pancreatic AdenocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- TH-302Phase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- TH-302Phase 2 · Soft Tissue SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- TH-302 combination with pemetrexedPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- ZalifrelimabPhase 2 · Metastatic Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- IMGS-001Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Nab-paclitaxelPhase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- TH-302Phase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Study of Evofosfamide in Combination With Zalifrelimab and BalstilimabPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 8, 2025ClinicalTrials.gov NCT06782555 · fetched Nov 12, 2026
- Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid TumorsPHASE1 · RECRUITING · started Sep 7, 2023ClinicalTrials.gov NCT06014502 · fetched Nov 12, 2026
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung CancerPHASE2 · TERMINATED · started Jun 1, 2014ClinicalTrials.gov NCT02093962 · fetched Nov 12, 2026
- Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerPHASE1 · TERMINATED · started Jan 1, 2014ClinicalTrials.gov NCT02047500 · fetched Nov 12, 2026
- A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced MelanomaPHASE2 · TERMINATED · started May 1, 2013ClinicalTrials.gov NCT01864538 · fetched Nov 12, 2026
- Clinical Trial Testing TH-302 in Combination With Gemcitabine in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic AdenocarcinomaPHASE3 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01746979 · fetched Nov 12, 2026
- Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic AdenocarcinomaPHASE2 · COMPLETED · started Jun 1, 2010ClinicalTrials.gov NCT01144455 · fetched Nov 12, 2026
- Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue SarcomaPHASE1_PHASE2 · COMPLETED · started Aug 1, 2008ClinicalTrials.gov NCT00742963 · fetched Nov 12, 2026